Abstract
BackgroundIn patients with stage III melanoma, despite surgical resection and adjuvant systemic therapy, locoregional recurrences still occur. The randomized, phase III Trans-Tasman Radiation Oncology Group (TROG) 02.01 trial demonstrated that...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have